header API report 540x680@2x
NICE INSIGHT REPORT

Active Pharmaceutical Ingredients, API: 2024 Market Insight, CDMO Pricing and Competitor Benchmarking

Published March, 2024
  • 110 CDMO profiles detailing capabilities and services
  • 2024 global manufacturing pricing study with hard-to-find CDMO pricing data
  • Pricing of 45 line items spanning development through cGMP manufacturing
  • Two project case studies (10,000 kg and 20,000 kg scale)
  • Trend analysis of the rise of HPAPIs and small-volume manufacturing
header API report 540x680@2x

Key market insights for innovators, CDMOs and investors in the Active Pharmaceutical Ingredient industry.

01 analysis icon 65x65@2x

Stay ahead of the ever-changing API market — from emerging products, manufacturing changes and regulatory trends

The API market is constantly evolving on three fronts: product, development and manufacturing. Stay ahead of all three with our comprehensive report. Leaders in API manufacturing use our Market Analysis for an unobstructed report of the modalities receiving funding and the technology getting medicine to patients more efficiently.
02 benchmarking icon 65x65@2x

Make informed decisions with our extensive pricing study

The Market Analysis provides exclusive pricing research that is invaluable to API manufacturers. Benchmark your business against your peers and effectively strategize for the future of manufacturing with up-to-date pricing info.

Published January, 2024

The Market Insight report is the only comprehensive analysis that combines scientific expertise with strategic business insights for a competitive advantage.

The Active Pharmaceutical Ingredients, API: 2024 Market Insight, CDMO Pricing and Competitor Benchmarking provides

01 profiles icon 65x65@2x
110 company profiles for competitive analysis — includes capabilities, technologies and location
02 benchmarks icon 65x65@2x
API manufacturing pricing study to benchmark against your peers with historical and current primary data with pricing of 45 individual line-items
03 scientific analysis icon 65x65@2x
Expert analysis on the new leading indications and why they’re appealing to investors
04 technology icon 65x65@2x
New analytical technology and how data is leading a manufacturing revolution
05 market projections icon 65x65@2x
Manufacturing trends and the new technologies getting patients the drugs they need
06 regulation icon 65x65@2x
API regulation and how businesses are staying strictly compliant

Over 750 hours of data collection and analysis including
primary pricing information and one-on-one interviews with API leaders.

Table of Contents

Executive Summary

Study Methodology

Section I:

Small Molecule API Market Overview

  • Size and Growth Rate
  • Branded/Generic
  • Sourcing Issues
  • Capacity Issues
  • Drug Shortages

Section II:

Small Molecule API Market Trends

  • Leading Indications
  • Orphan Drugs
  • Personalized Medicine
  • Highly Potent APIs
  • Controlled Substances
  • More First-in-Class Drugs

Section III:

Small Molecule API Discovery and Development Trends

  • Quality-by-Design
  • High-Throughput Screening
  • Digitalization of R&D
  • Shrinking Development
  • Addressing Sustainability

Section IV:

Small Molecule API Manufacturing Trends

  • Green Processing
  • Electrochemistry
  • Chiral Technologies
  • Advances in Chemocatalytic Solutions
  • Advances in Enzymatic Technologies
  • Growing Need for API Processing
  • Rising Importance of Small-Volume Manufacturing
  • Increasing Containment Needs
  • Increasing Automation
  • Process Intensification / Continuous Processing
  • Adoption of Single-Use Technologies
  • University Participation Accelerating
  • Customization and Personalization
  • Modular Manufacturing
  • Supply Chain Resilience
  • Regulatory Harmonization
  • Increasing Role for Outsourcing

Section V:

Small Molecule API Analytical Trends

  • More Sophisticated, Sensitive, and Smaller Instruments
  • Growing Importance of Digitalization and Software Platforms
  • Growing Use of Process Analytical Technologies
  • Nitrosamine Impurity Testing

Section VI:

Small Molecule API Regulatory Trends

Section VII:

Small Molecule API Contract Development and Manufacturing Market

  • Overall Market Size and State
  • Recent Investments
  • Regional Analysis

Section VIII:

Small Molecule API Outsourced Manufacturing Pricing Study

Section IX:

API Contract Outsourcing Company Analysis

Appendix I:

References

API report form@2x
Published January, 2024
Request a quote for the Active Pharmaceutical Ingredients, API: 2024 Market Insight report

API report form@2x